Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endo International PLC (NASDAQ:ENDP)

85.11
Delayed Data
As of Aug 04
 -1.88 / -2.16%
Today’s Change
57.14
Today|||52-Week Range
96.58
+18.01%
Year-to-Date

Today’s Trading

Previous close86.99
Today’s open87.16
Day’s range84.64 - 87.28
Volume1,911,305
Average volume (3 months)2,323,542
Market cap$17.9B
Dividend yield--
Data as of 3:59pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+18.84%
Earnings growth (this year)+4.81%
Earnings growth (next 5 years)+12.90%
Revenue growth (last year)+9.95%
P/E ratioNM
Price/Sales3.68
Price/Book5.67

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+5.76+5.54%
HSPHospira Inc+0.07+0.08%
MNKMallinckrodt Plc0.000.00%
BMRNBiomarin Pharmaceuti...-3.39-2.30%
Data as of 4:14pm ET, 08/04/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)$1.02
Annual revenue (last year)$2.9B
Annual profit (last year)-$721.3M
Net profit margin-25.14%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Rajiv De Silva
SVP-Operations, Research &
Development Strategy
Robert J. Cobuzzi
Corporate headquarters
Dublin, Dublin

Forecasts